News

The company believes YKP10811 possesses a range of efficacy in both the upper and lower GI tract and an improved safety profile. The program is expected to develop

The new resin is a designed tool for the GMP-regulated purification of antibodies and antibody fragments that contain a lambda light chain. GE Healthcare Life Sciences custom design

Under the agreement, each AstraZeneca project will involve either BioFocus or Argenta’s medicinal chemistry, biology and ADME/PK capabilities, and will also be able to access the full suite

The company is conducting a pivotal Phase III study in soft tissue sarcoma comparing TH-302 in combination with doxorubicin against single agent doxorubicin. The same combination regimen of

Under the deal, ViroPharma is also investing in new equipment to increase the manufacturing capacity for Plenadren in order to support commercial product launches across Europe. Recipharm Stockholm

Health minister of Ghana, Alban Bagbin said the project will help the country to stop the perennial importation of the drugs from developed countries. The company also exports

ZO Medical utilizes the most potent ingredients in high concentrations, pure retinol, advanced peptides, and powerful antioxidants. The products work from the inside out, activating and stimulating skin’s

As per the agreement, ThromboGenics will receive an upfront payment of €75m and also a further €90m in potential near-term milestone payments. Additional milestones bring the potential total

The company plans to launch CAMBIA (diclofenac potassium for oral solution) in Canada in the second half of 2012. The water-soluble, buffered diclofenac potassium powder was developed leveraging